EUVIMEDEUVIMED entdecken
Crossref

Autologous chondrocyte implantation for the treatment of osteochondral lesions of the talus: What happens after 20 years?

Valentina Viglione, Luca Berveglieri, Giuseppe Filardo, Roberto Buda, Sandro Giannini, Cesare Faldini, Francesca Vannini

Foot and Ankle Surgery · 2024

DOI: 10.1016/j.fas.2024.04.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Foot and Ankle Surgery, 2024. Verfasst von Valentina Viglione und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinica Ortopedica e Traumatologica 1; IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy. Hauptthemen laut MEDLINE: Talus, Chondrocytes, Transplantation, Autologous. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The purpose of this study was to assess the long-term clinical efficacy of first-generation autologous chondrocyte implantation (ACI) technique for osteochondral lesions of the ankle joint. METHODS: Eleven patients with symptomatic OLTs underwent ACI from December 1997 to October 2002. A total of 9 patients (5 men, 4 women, age 25.2 ± 6.3) were evaluated at baseline and at 1, 3, 10 years, and at final follow-up of minimum 20 years with AOFAS ankle-hindfoot score, NRS for pain, and with the Tegner score. RESULTS: The AOFAS score improved significantly from the baseline value of 40.4 ± 19.8 to 82.7 ± 12.9 at the final follow-up (p < 0.0005). The NRS for pain improved significantly from 7.8 ± 0.7 at baseline to 4.8 ± 2.1 at the final follow-up (p < 0.0005). Moreover, the Tegner score underwent a modification from the pre-operative median value of 1 (range: 1-3) and from a pre-injury value of 5 (range: 3-7) to 3 (range: 2-4) at the final follow-up (p < 0.0005). CONCLUSIONS: ACI has proven to be an effective treatment option for patients suffering from OLTs, leading to a long-lasting clinical improvement even beyond 20 years of follow-up. LEVEL OF EVIDENCE: Level IV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TalusChondrocytesTransplantation, AutologousHumansFemaleMaleAdultYoung AdultFollow-Up StudiesCartilage, ArticularTreatment OutcomeAnkle JointTime FactorsRetrospective StudiesAdolescent

Stichwörter der Autor:innen

AnkleAutologous Chondrocyte ImplantationCartilageOsteochondral lesionTalus

Autor:innen und Institutionen

  • Clinica Ortopedica e Traumatologica 1; IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
  • Clinica Ortopedica e Traumatologica 1; IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy. Electronic address: luca.berveglieri@ior.it.
  • Applied and Translational Research (ATR) Center; IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
  • Clinica Ortopedica di Chieti, Ospedale Clinicizzato SS Annunziata di Chieti, Chieti, Italy.
  • Alma Mater Studiorum-Università di Bologna, Bologna, Italy.

Zitieren

APA

Viglione, V., Berveglieri, L., Filardo, G., Buda, R., Giannini, S., Faldini, C., & Vannini, F. (2024). Autologous chondrocyte implantation for the treatment of osteochondral lesions of the talus: What happens after 20 years?. Foot and Ankle Surgery. https://doi.org/10.1016/j.fas.2024.04.007

Vancouver

Viglione V, Berveglieri L, Filardo G, Buda R, Giannini S, Faldini C, et al. Autologous chondrocyte implantation for the treatment of osteochondral lesions of the talus: What happens after 20 years?. Foot and Ankle Surgery. 2024. doi:10.1016/j.fas.2024.04.007

BibTeX
@article{Viglione2024,
  author = {Viglione, Valentina and Berveglieri, Luca and Filardo, Giuseppe and Buda, Roberto and Giannini, Sandro and Faldini, Cesare and Vannini, Francesca},
  title = {Autologous chondrocyte implantation for the treatment of osteochondral lesions of the talus: What happens after 20 years?},
  journal = {Foot and Ankle Surgery},
  year = {2024},
  doi = {10.1016/j.fas.2024.04.007}
}
Kostenlos starten →